Fasedienol | Interleukin Related interleukin-related.com

Product Name :
Fasedienol

Search keywords :
BNS

drugId :
null

Target Vo:
Gamma-aminobutyric acid A receptor

Target Vo Short Name :
GABAAR

Moa_Name:
Sensory receptor modulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Pherin Pharmaceuticals Inc

Active Company_Name :
Affamed Therapeutics Ltd

Active Indication_Name:
Phobia, Social

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Foralumab Data Sheet
Nimotuzumab EGFR
CD40L Antibody: CD40L Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 29 kDa, targeting to CD40L. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts